Watching short, web-based tutorials that inspire health care workers to contemplate awe, gratitude and kindness can promote enduring improvements in mental health outcomes such as depression and emotional exhaustion.
Replimune kickstarts Phase III melanoma trial studying RP1 immunotherapy – Pharmaceutical Technology
IGNYTE-3 tests the efficacy of RP1 against melanoma when other treatments have failed Replimune has announced the first patient in the Phase III melanoma trial